Invention Grant
- Patent Title: Simmondsin formulation
-
Application No.: US16178850Application Date: 2018-11-02
-
Publication No.: US11406678B2Publication Date: 2022-08-09
- Inventor: Stefaan Raes , André D'Oosterlynck
- Applicant: Stefaan Raes , Herman Van Den Driessche
- Applicant Address: BE Merelbeke; BE Oudenaarde
- Assignee: Stefaan Raes,Herman Van Den Driessche
- Current Assignee: Stefaan Raes,Herman Van Den Driessche
- Current Assignee Address: BE Merelbeke; BE Oudenaarde
- Agency: Hovey Williams LLP
- Main IPC: A61K36/00
- IPC: A61K36/00 ; A61K36/185 ; A61K31/7034 ; A23L33/105 ; A61K31/277 ; A61K9/48 ; A61K9/107 ; A23L33/135 ; A61P27/02 ; A61P25/28 ; A61P17/00 ; A61P19/02 ; A61P25/16 ; A61P35/00 ; A61K31/192
Abstract:
A human oral at least partly enteric formulation comprising one or more jojoba components, for controlling, stimulating or modulating functions for patients suffering from a degenerative disease, or for patients at risk from suffering from a degenerative disease, or for patients under therapeutic treatment of a degenerative disease.
Public/Granted literature
- US20190070238A1 SIMMONDSIN FORMULATION Public/Granted day:2019-03-07
Information query
